Piperonyl Butoxide

Piperonyl Butoxide

SCHEMBL104661

CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2.[RbH]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

82298078230507823050882308198230924823093782309578231029823151182323108232678823291582336198233620823362182338238234154823440782344088234840823547582360878236088823610082369748237447823761882377958238085823808682383438238380823840482399208240195

The experimentally established mechanism targets of Piperonyl Butoxide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.97
ALDH1A1 P00352 4/20 0.97
TSHR P16473 1/20 0.97
HPGD P15428 2/20 0.44
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2D6 P10635 3/20 0.37
CYP2C19 P33261 3/20 0.37
CYP2C9 P11712 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
SCN1A P35498 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
HTT P42858 2/20 0.34
MAOB P27338 2/20 0.34
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperonyl Butoxide SCHEMBL29386186 0.98 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL5490 0.98 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL1517385 0.98 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHPGDMEN1
SCHEMBL9958244 0.98 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL6561910 0.98 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL11895741 0.97 CYP3A4 (0.97) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL16105717 0.97 CYP3A4 (0.97) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL4809313 0.97 CYP3A4 (0.97) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL2588661 0.97 CYP3A4 (0.97) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL1654891 0.97 CYP3A4 (0.97) CYP3A4ALDH1A1TSHRHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025243002-A1 FLUORINATION PROCESS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-11-27 WO disclosed
EP-2241546-B1 PROCESS FOR PRODUCTION OF BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2017-10-04 EP disclosed
EP-2426098-B1 PROCESS FOR PRODUCING POLYHYDRIC PHENOL MITSUI CHEMICALS INC (JP) 2015-01-21 EP disclosed
US-8604253-B2 Method for producing polyhydric phenol MITSUI CHEMICALS, INC. (JP) 2013-12-10 US disclosed
US-8258349-B2 Process for production of benzaldehyde compound SUITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-09-04 US disclosed
EP-2426098-A1 PROCESS FOR PRODUCING POLYHYDRIC PHENOL Mitsui Chemicals, Inc. (JP) 2012-03-07 EP disclosed
US-20120046498-A1 METHOD FOR PRODUCING POLYHYDRIC PHENOL MITSUI CHEMICALS, INC. (JP) 2012-02-23 US disclosed
US-20100292513-A1 PROCESS FOR PRODUCTION OF BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-18 US disclosed
EP-2241546-A1 PROCESS FOR PRODUCTION OF BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-10-20 EP disclosed
EP-1806333-A1 A method for manufacturing dialkyl carbonate GENERAL ELECTRIC COMPANY (US) 2007-07-11 EP disclosed
EP-1299341-B1 A METHOD FOR MANUFACTURING DIALKYL CARBONATE GEN ELECTRIC (US) 2007-04-25 EP disclosed
EP-1299341-A2 A METHOD FOR MANUFACTURING DIALKYL CARBONATE GENERAL ELECTRIC COMPANY (US) 2003-04-09 EP disclosed
US-6458914-B2 REACTING CARBON MONOXIDE, OXYGEN AND ALCOHOL IN THE PRESENCE OF A CATALYST PRODUCED BY REACTING TOGETHER AND INCLUDING A CUPRIC HALIDE AND AN ALKOXIDE COMPOUND OF A GROUP III THROUGH VII METAL; EFFICIENCY; ANTIFOULING AGENTS GENERAL ELECTRIC COMPANY 2002-10-01 US disclosed
EP-1189870-A1 METHOD FOR MANUFACTURING DIALKYL CARBONATE GENERAL ELECTRIC COMPANY (US) 2002-03-27 EP disclosed
US-20020007087-A1 Method for manufacturing dialkyl carbonate SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2002-01-17 US disclosed
WO-2002000596-A2 A METHOD FOR MANUFACTURING DIALKYL CARBONATE GENERAL ELECTRIC COMPANY (US) 2002-01-03 WO disclosed
US-6258923-B1 REACTING CARBON MONOXIDE, OXYGEN AND ALCOHOL GENERAL ELECTRIC COMPANY 2001-07-10 US disclosed
WO-2000076950-A1 METHOD FOR MANUFACTURING DIALKYL CARBONATE GENERAL ELECTRIC COMPANY (US) 2000-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292513-A1 PROCESS FOR PRODUCTION OF BENZALDEHYDE COMPOUND CBR3, ADH5, ALDH1A1 CYP3A4 102/4885ALDH1A1 3/4885TSHR 3370/4885
US-20120046498-A1 METHOD FOR PRODUCING POLYHYDRIC PHENOL HPD, HAAO, SCO2 CYP3A4 462/4885ALDH1A1 969/4885TSHR 2762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.